1518 GMT - The health system in the U.K. needs to develop a more attractive investment environment, AstraZeneca's chief executive officer Pascal Soriot says in a media call. High taxes and access issues have created problems for the entire industry, he says. The British pharma giant last week withdrew plans to invest in a vaccine plant in Liverpool after what it called a cut in government support. Shares are up 5.8% at 117.70 pounds. (helena.smolak@wsj.com)
(END) Dow Jones Newswires
February 06, 2025 10:18 ET (15:18 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.